Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Analyst
Dara Mohsenian
Period: Reporting periods mapped to calendar 2024 Q3 – 2026 Q3 (9 quarters).
- Questions
- 77on tracked calls
- Challenge rate
- 10%8 of 77 questions
- Companies
- 11questioned at least once
- Reporting periods
- 9with questions
These figures cover the whole profile: every tracked question, all reporting periods.
How to read these numbers
Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.
Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.
No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.
Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.
Small samples. Profiles with fewer than 10 questions are marked Limited sample.
Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.
Questions asked
Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.
Showing 77 of 77 questions from 11 companies
PEPPepsiCo10 questions · 8 reporting periods · 1 of 10 challenging
Calendar 2026 Q3
Just would love your thoughts on the sustainability of the strong growth that you're seeing internationally
Show response
Laguarta called international strength structural and broad-based rather than weather-driven, and said NA snacks volume turned positive while beverages lag.
Steve, if I can just slip in one on the margin side, obviously the earnings revision in Q4 is margin driven
Show response
Schmitt tied the EPS cut to margins (input costs, mix) with sales holding and investment sustained, but declined to frame 2027 until February.
Calendar 2026 Q2
you might need some level of greater spending, a bit of an earnings reset as you look out?
Show response
Laguarta rejected the need for an earnings reset, citing record H1 productivity to fund affordability, portfolio transformation, and away-from-home investment; U.S. can grow ~3% longer term.
Calendar 2026 Q1
can you highlight what's changed in terms of your cost assumptions? Any sizable pressure points individually
Show response
Steve provided a comprehensive answer covering supply chain resilience, hedging programs (6-12 month), and a three-pronged inflation mitigation strategy.
touch on the international regions if you're seeing any impact from the conflict later in March or April so far
Show response
Ramon stated clearly that international demand continues to accelerate with no conflict impact, and PepsiCo has better supply chain than competitors in some markets.
Calendar 2025 Q4
Are you seeing volume pick up more than the price investments? Is it close to the price investments?
Show response
Ramon confirmed tests at scale showed good ROI but didn't quantify specific volume/price payback ratio; emphasized post-rightsizing operating leverage on incremental volume.
Calendar 2025 Q3
which areas do you think are most impactful as we think about potentially accelerating revenue growth in 2026
Show response
Ramon gave extensive roadmap: brilliant at basics, big brand relaunches (Lay's/Tostitos/Gatorade), away-from-home acceleration, permissible snacks, functional hydration, protein innovation, and M&A platforms (Poppi, Alani Nu). Expects algorithm return during 2026.
Calendar 2025 Q2
just help us understand your visibility and the assumptions behind the acceleration in the back half of the year relative to the first half
Show response
Jamie expressed high confidence in H2 productivity ramp with actions already identified and some executed. Ramon detailed reinvestment in technology, surgical value investments, away-from-home, and maintaining A&M levels.
Calendar 2025 Q1
if at some point you think we might need a more substantial level of re-investment behind FL&A to turn around trends in that business
Show response
Jamie emphasized protecting long-term franchise health and driving productivity to fund investments; Ramon detailed three equally important pillars and highlighted SAP implementation now behind them.
Calendar 2024 Q4
how you're specifically managing the business differently in 2025 relative to the back half of last year on both the Frito-Lay and beverage side
Show response
Ramon gave extensive detail on beverage margin path to mid-teens, Frito innovation in zero-sugar/functional/permissible, and international as the primary growth engine.
PGThe Procter & Gamble Company9 questions · 8 reporting periods · 0 of 9 challenging
Calendar 2026 Q2
what are the biggest areas or initiatives left to put in place versus what is already been implemented
Show response
Jejurikar walked through China, Latin America and AMA recovery evidence and said U.S. interventions land in the front half, but gave no timing commitment for category outperformance.
Calendar 2026 Q1
Are you comfortable that you're back to organic sales growth outperformance versus your categories going forward
Show response
Andre confirmed outperformance is the goal and was achieved in Q3 but could not promise it every quarter. Said the mass of interventions is reaching a point of sustained momentum.
can you discuss if you can see any advantage on relative sales performance versus competitors
Show response
Andre said it is too early to assess but expressed confidence based on historical resilience. Noted competitors with long or heavily contract-manufactured supply chains tend to struggle more.
Calendar 2025 Q4
what are the most important priorities for the organization in terms of driving better execution
Show response
Shailesh cited three changes: new media landscape brand-building, stronger core/bigger more innovation mix, and deliberate consumer value strengthening without price changes.
Calendar 2025 Q3
how do you think the organizational changes are being received internally by your workforce
Show response
Andre said execution is on track across portfolio, supply chain and organization, with smaller digitally-enabled brand teams as the end state.
Calendar 2025 Q2
can you discuss how the restructuring you recently announced will enable greater organizational capabilities
Show response
Jon framed the CEO change as timed to the fiscal year lap and described organization redesign as breaking functional silos with digital tools.
Calendar 2025 Q1
if we do start to see more consumer trade down, can you discuss how you see The Procter & Gamble Company is positioned
Show response
Andre highlighted vertical value portfolio, innovation across tiers (Tide/Gain, Swaddlers/Luvs), private label continuing to decline.
Calendar 2024 Q4
you've talked historically about the OSG split between the robust 85% in country mix versus a lagging 15%
Show response
Andre quantified the split: 85% core at ~4%, 15% improved led by China going from -15% to -3%.
Calendar 2024 Q3
Can you just touch on what you think sustained category growth is here in the US in a moderate pricing environment
Show response
Andre put US market growth at 3-4% and pointed to household-penetration and consumer-group growth opportunities.
STZConstellation Brands9 questions · 9 reporting periods · 3 of 9 challenging
Calendar 2026 Q3
if we should expect a broader push into RTDs from an M&A standpoint
Show response
Fink said beer remains the core, RTD moves will be selective, and SpikedAde was chosen as a differentiated first mover with a wide-open distribution runway.
Calendar 2026 Q2
Can you give us a bit more detail on how you execute that? Is it more marketing on base brands, more through innovation
Show response
Fink stressed the core portfolio as the top value driver, with occasion-based insight and disciplined white-space participation.
Calendar 2026 Q1
can you just break out what you're expecting from a key input cost standpoint in fiscal '27
Show response
Garth detailed hedging: fuel ~100%, aluminum ~90%, natural gas ~80%, corn ~75%, currencies ~80%. Volume is key margin upside driver. Wine margins depressed by category decline, Canada ban, distributor inventory rebalancing, and cost deleverage timing.
Calendar 2025 Q4
do you think it's realistic you can drive shelf space gains for your portfolio with macros where they are
Show response
Bill noted Modelo has 20% fewer PODs than domestic competitors despite being #1 by dollars, continued opportunity. 75% of Hispanic consumers still very concerned about socioeconomic environment.
Calendar 2025 Q3
How much impact do you think you're seeing from factors beyond the macro component
Show response
Bill dismissed GLP-1 impact, acknowledged cannabis could grow as a factor, cited Sunbrew's success targeting younger consumers. Emphasized spending more on marketing than ever, gaining share even in tough environment.
Calendar 2025 Q2
can you just discuss confidence in your Beer volume growth outlook? And at some point, it implies you move back to depletion growth
Show response
Bill noted Q1 lapped the strongest prior-year quarter, sequential improvement needed but not predicated on significant consumer change. Garth quantified incremental tariff at ~$20M (~20bps margin hit), still expects full-year margins in line with April guidance.
Calendar 2025 Q1
a pretty big revision in long-term beer sales growth from the 7% to 9% range to 2% to 4% in fiscal '27 and '28
Show response
Bill acknowledged the tension between 'non-structural' messaging and large guidance cuts, pointed to Pacifico up 16% and innovation pipeline as evidence of brand strength, said uncertainty on consumer sentiment timing drove the reset.
Calendar 2024 Q4
If you had to separate that out between the short-term consumer weakness you focused on with the subdued spend and the value-seeking behavior that you mentioned on the call versus some of the longe...
Show response
Bill acknowledged near-term headwinds lasted longer than expected but firmly dismissed structural concerns, noting alcohol's share of consumer basket remains consistent.
Calendar 2024 Q3
just can you give us a bit of postmortem there? Obviously, you talked about the macro factors
Show response
Bill attributed softness to Hispanic unemployment and election uncertainty, noted buy rate up mid-single digits on 52-week basis.
CLColgate-Palmolive8 questions · 7 reporting periods · 1 of 8 challenging
Calendar 2026 Q2
So just any perspective on your ability to continue to realize pricing in pet?
Show response
Noel addressed category softness and Hill's share directly, citing ex-private-label growth of 4% well above a roughly flat category.
Calendar 2026 Q1
North America continued to lag in Q1 and volume/mix. You did talk about improvement in Q2 in the published remarks
Show response
Acknowledged NA will take time. Cited brand interventions, accelerated innovation, better RGM, and improved retailer execution. Noted shelf resets and new products shipped late but improvement seen exiting Q1.
I just wanted to focus on volume mix. You clearly had strong results in emerging markets in Q1
Show response
Noel attributed EM volume strength to sustained high ad investment, brand strength, and improved execution at Hawley & Hazel. Noted broad-based growth across all divisions and categories.
Calendar 2025 Q4
I'd just love to get your perspective on category growth within that guidance as you look at key regions around the world
Show response
Wallace gave clear framework: low end if categories worsen, middle if stable, high end if strengthen. Categories stabilized at 1.5-2.5%. Sutula noted FX low single-digit top-line benefit focused on H1, used as P&L flexibility.
Calendar 2025 Q3
Can you just give us some perspective on if you expect the category softness to linger as we look out to 2026
Show response
Wallace detailed month-to-month volatility with surprising swings. 2030 strategy changes being made from position of strength. North America improving ex-skin. Hill's 2.5% organic ex-PL with broad-based growth.
Calendar 2025 Q2
What are the key operational changes? How should we think about the savings payback versus the charges? And why now?
Show response
Wallace positioned program as catalyst for 2030 strategy covering innovation, AI, omnichannel. Sutula outlined $200-300M over 3 years. On US, cautious consumer with June step-back after April-May rebound.
Calendar 2025 Q1
just can you give us a bit more detail on what you are seeing at a consumer level given some of the broader macro concerns
Show response
Wallace reported very strong LatAm market shares, Africa/Middle East growing. China Colgate brand up mid-single-digit organic. Hawley and Hazel and India urban remain soft.
Calendar 2024 Q4
EPS guidance for all-in low-single-digit to mid-single-digit growth is pretty robust considering the onerous FX impact
Show response
Wallace cited P&L flexibility, balance sheet strength, strong brand health, and market share gains as underpinning confidence. Addressed Q4 organic as 5% ex-private label.
ELEstée Lauder Companies (The)7 questions · 7 reporting periods · 0 of 7 challenging
Calendar 2026 Q1
I was hoping to maybe get a bit more perspective on long-term margin potential
Show response
Stephane outlined 500bps expansion from 8% to potential 13% by FY2027 year-end. Gross margin up 140bps in Q3, nonconsumer-facing down 4% consistently. New operating model with Accenture, Shopify, WPP built for leverage. Margin recovery described as a milestone not a sprint. At mid-to-high end of FY2027 view, would be gaining market share which creates additional operating leverage.
Calendar 2025 Q4
Could you give us a sense now that calendar 2025 is in the books how much of your business has shifted more to the what you characterize as higher growth channels
Show response
Stephane confirmed department stores now 30% or less of North America business. 12 brands on Amazon US. MAC entering Sephora US within weeks. Freestanding stores and DTC growing. Luxury fragrance stores expanding. The Ordinary in high double-digit growth driving volume share gains entirely through high-growth channels. Brand positioning from La Mer to The Ordinary captures full prestige spectrum.
Calendar 2025 Q3
is that conservatism or early in the year? Trying to understand if the Q1 result gives you more optimism
Show response
Stephane explained front-half/back-half dynamics: H1 benefits from lapping weak China and Travel Retail comps, H2 faces tougher comparisons as recovery began last year. Trade policy volatility and subdued Western consumer sentiment warrant caution. Akhil confirmed Q2 expected to see similar strengths with strong holiday plans. Golden Week in China was strong with share gains.
Calendar 2025 Q2
How much progress have you made so far? What changes are left to be implemented in fiscal '26?
Show response
Stephane confirmed new leadership team nearly complete with R&D head announcement imminent. Seven regions collapsed into four new geographic clusters effective July 1. P&L responsibility shifted from brands to regions. Compensation restructured around Beauty Reimagined execution. Described it as the biggest organizational transformation in company history.
Calendar 2025 Q1
What are the most important building blocks in your mind to get back to better market share performance consistently across the organization
Show response
Stéphane detailed U.S. position: Clinique #1 and M·A·C #2 in makeup; Clinique #1 and The Ordinary #2 in skincare. In China, 8+ brands gaining share. Intent to take U.S./China/Japan learnings to U.K. and emerging markets.
Calendar 2024 Q4
I was just hoping also to get a bit more perspective from you on the softer cultural changes, among the workforce that are needed
Show response
Stéphane committed to building agility through culture change. Acknowledged need for external partners in transformation execution. Akhil emphasized three cultural pillars: ownership, consumer-centricity, and value creation.
Calendar 2024 Q3
can you give us a bit more detail on how much more aggressive you can get on cost structure, the potential areas you're looking at
Show response
Tracey confirmed additional cost savings being identified. Fabrizio added focus on improving investment quality through precision marketing and winning channels.
KOThe Coca-Cola Company7 questions · 7 reporting periods · 1 of 7 challenging
Calendar 2026 Q2
Can you just confirm, is everything on track in terms of that incremental Webster capacity ramp-up?
Show response
Confirmed the ramp is on plan and that main SKUs come before innovation while capacity is added.
Calendar 2026 Q1
I just was hoping to get your view on the balance between volume versus price/mix in the remainder of the year
Show response
Henrique confirmed balanced 3/2 or 2/3 volume-to-price/mix algorithm expected through the year, with pricing embedded in RGM architecture.
Calendar 2025 Q4
I just wanted to get into the nitty-gritty of the 4% to 5% organic sales growth outlook for 2026
Show response
James urged 4-quarter view on mix. Underlying pricing was 4% with negative mix effects evening out over time. Expects more balanced volume/price split in 2026 as inflation moderates.
Calendar 2025 Q3
just want to dive a bit deeper into Latin America
Show response
Henrique noted Brazil, Colombia and Chile grew while Mexico progressing but not yet recovered. Macroeconomic issues persist with plans in place requiring more time.
Calendar 2025 Q2
how much of an unlock the planned US capacity additions are starting in early 2026 for Fairlife
Show response
James confirmed New York facility online early 2026 with ramp through the year. Capacity bottleneck narrowing to H2 2025/early 2026. Santa Clara strong in Mexico as value-added dairy.
Calendar 2025 Q1
is that just because it's early in the year and in a difficult environment, it doesn't make sense to raise overall earnings
Show response
John cited early-year prudence and EM currency volatility as reasons for not flowing through FX improvement. Emphasized full-year view over quarterly dynamics.
Calendar 2024 Q4
just on that 5% organic revenue growth forecast for 2025, can you just give us a bit more granularity on the balance volume
Show response
Management detailed expectation of 2-3% each for volume and price, noted 2025 will be slightly more price-weighted than typical.
Show 5 more companies
MNSTMonster Beverage7 questions · 7 reporting periods · 0 of 7 challenging
Calendar 2026 Q2
Are there incremental areas from here where you think about incremental penetration
Show response
Hilton pointed to FSOP (Marriott), new 12-ounce packs, Gen Z and women driving growth, and zero sugar over 75% of category growth; Rob added innovation recruits consumers at nearly twice the category rate.
Calendar 2026 Q1
I was just hoping you could review the performance of some of the key innovations so far year-to-date
Show response
Hilton noted innovation was staggered across the first half rather than front-loaded. Guy Carling highlighted Viking Berry as the most successful EMEA innovation ever and that Ultra White grew over 50% in EMEA.
Calendar 2025 Q4
Just wanted to touch on your market share gains internationally. It's really accelerated in recent periods
Show response
CEO disclosed affordable energy reached ~100M unit cases in 2025, with key markets in Nigeria, Egypt, Kenya, Mexico, India, China. EMEA CEO Carling noted 2/3 of EMEA growth from existing SKUs vs 1/3 innovation, with Ultra platform growing 53% in Q4.
Calendar 2025 Q3
I just wanted to touch on EMEA revenue growth, strong reported results in the last couple of quarters
Show response
CEO attributed EMEA strength to value proposition vs NARTDs, brand image, functionality, viral Ultra social media surge, and innovation including Lando Norris. Noted growth driven from both innovation and existing SKUs, unlike competitors dependent mainly on innovation.
Calendar 2025 Q2
The gross margin performance was particularly strong in Q2. Can you just talk about how sustainable some of those drivers might be going forward?
Show response
CEO indicated Q4 pricing expected to help offset tariff pressure in Q3/Q4. Hedging strategy in place for LME aluminum but limited Midwest premium hedging. Pricing details still depend on packaging channel.
Calendar 2025 Q1
just wanted to get any perspective on if you think we're seeing any macro impact on the category, either in the U.S. or internationally
Show response
CEO emphasized Nielsen depletions over shipment data as better indicator of health. Category healthy with improving trends through April. Co-CEO cited bottler reports: CCP +12%, Hellenic +26%, Korea LG +45.8%.
Calendar 2024 Q4
Can you also just give us some color or any thoughts on Monster's potential U.S. market share performance as we look going forward?
Show response
Management highlighted low-single-digit shelf space gains, $21.2B US category scale, innovation pipeline including Blue Hawaiian as top-10 seller. Acknowledged competition but emphasized two-player market with Red Bull.
KMBKimberly-Clark6 questions · 3 reporting periods · 1 of 6 challenging
Calendar 2026 Q1
walk us through the range of potential actions you would take to help offset any pressure on full year earnings if oil stays up here
Show response
Urdaneta detailed PNOC toolkit: RGM, 6% productivity, supplier renegotiation, hedging. 80% cost basket covered. Track record of recovering $200M costs per year in 2024-2025 while expanding margins.
strategically how you plan to manage pricing in North America given all those factors
Show response
Torres confirmed North America promo below category and 2019 levels. Innovation-driven trial promotion in diapers expected to normalize through 2026. PNOC discipline maintained.
Calendar 2025 Q1
how much of that have you seen so far versus it's more of a forward expectation
Show response
Hsu confirmed value-seeking is already evident with migration to opening price point packages and larger count sizes. Not purely forward-looking.
why is the situation more burdensome than previously believed? Can you give us some detail on where specifically the incremental $300 million is coming from
Show response
Urdaneta broke down: China 145% tariffs ~67% (finished goods), US reciprocal ~10%, retaliatory ~25%. Expect to address one-third this year through supply chain re-optimization.
Calendar 2024 Q4
give us a review of where you think you stand on the organizational front with the rewiring plans you announced at Analyst Day
Show response
Hsu provided comprehensive answer covering penetration trends, frequency, trade-up opportunity and category growth outlook of 2% to 3% long-term.
take me through your decision process on pricing, particularly given some FX pressure and how you think about the balance between price and volume
Show response
Urdaneta clearly outlined pricing trajectory decline from 450bps Q1 to 160bps Q4 and expectation for flat pricing in 2025.
CHDChurch & Dwight5 questions · 3 reporting periods · 1 of 5 challenging
Calendar 2025 Q2
any thoughts, Rick, on your ability to return to the Evergreen OSG targets after this year?
Show response
CEO characterized 2025 as aberration driven by category deceleration from tariff uncertainty. Portfolio pruning of slower-growth brands strengthens ability to hit Evergreen going forward.
BATISTE, it's been a great growth brand in recent years, slowdown in Q2, you sound more optimistic in the back half
Show response
CEO cited multiple factors: supply chain issues (resolved), competitor price increase disrupting category, and economic pressure driving trade-down. Confident in medium-term share gains.
Calendar 2025 Q1
the tracked channels and it does look like it's decelerated in terms of your share so far in April
Show response
CEO firmly stated never assumes share loss. Expects continued share gains from portfolio strength, advertising, innovation, and promotional programs.
might share repurchases a greater priority perhaps there's more M&A opportunities from an external environment standpoint
Show response
CEO reaffirmed M&A as top capital allocation priority with ~$6B capacity. Buybacks only if M&A dry spell persists. CFO echoed M&A discipline as key reason he joined.
Calendar 2024 Q4
any initial thoughts under your leadership as to maybe where you’ll double down on or areas you emphasize more?
Show response
Dierker identified three priorities: accelerating international growth (under-indexed to peers), making bigger bets on innovation, and identifying brands with untapped growth potential among the 80-brand portfolio. Stated no expectation of gaining vitamin shelf space until business shows inflection.
CLXClorox5 questions · 3 reporting periods · 0 of 5 challenging
Calendar 2025 Q1
I'd love to hear your perspective on what's driving the category weakness we're seeing.
Show response
Linda walked through timeline: through mid-Feb in line with expectations, then wallet shift to big-ticket purchases, then broader conserving behavior. Categories flat to down low-single digits. Not seeing trade-down to private label. Q4 April similar to back half of Q3.
Calendar 2024 Q4
How confident are you in continued expansion over time, A, and then B, what are the longer-term drivers?
Show response
Kevin confirmed confidence in 25-50bps EBIT margin expansion starting FY2026 driven by ERP productivity, design-to-value, and net revenue management.
why did this happen now? But with this change and the strength in financial profile in recent quarters, maybe you can just talk about if M&A is expected to be a more important piece of the strategy...
Show response
Linda said timing driven by contract expiration, both parties agreed not to renew. No change to M&A priorities or uses of cash. Retains important IP developed jointly with P&G.
Calendar 2024 Q3
can you talk about what you're seeing from a promotional environment perspective in the industry
Show response
Linda said promo largely returned to pre-COVID levels. Litter is the exception with significantly higher promotional levels.
do you think you can consistently expand share, maybe talk about some of the key drivers behind that
Show response
Linda confirmed share fully recovered pre-cyber, expects continued growth albeit lumpier during lap period.
KDPKeurig Dr Pepper4 questions · 3 reporting periods · 0 of 4 challenging
Calendar 2026 Q1
Can you just give us a bit more detail under the hood on what's driving the momentum in a segment and brand level and how sustainable you think those growth drivers are going forward?
Show response
Tim cited innovation slate including Canada Dry Fruit Splash and Dr Pepper Creamy Coconut, DSD distribution gains, stepped-up precision marketing. Noted Q1 net sales benefited from incremental GHOST distribution and outsized partner brand growth that will moderate. Anthony confirmed Q1 as peak coffee cost headwind with larger improvement in H2.
Calendar 2025 Q2
I just was hoping you could give us a review of the biggest changes you put in place
Show response
Tim described marketing transformation with data, technology, and digital at center. AI-enabled content creation. New personalized Fansville season for Dr Pepper in Q3. Digital targeting for Keurig households.
Calendar 2025 Q1
Can you just discuss the sustainability of those drivers going forward, particularly in the context of a weaker consumer environment?
Show response
Tim cited Dr Pepper share gains, Canada Dry share gains, 7UP back to share growth. Growth largely driven by base business volume and mix. Acknowledged tariffs may require additional pricing later.
Just can you discuss high-level, your level of confidence in maintaining the local FX guidance in 2025?
Show response
Sudhanshu detailed primary EPS drivers including U.S. RB and international profit flow, GHOST accretion, and productivity. Acknowledged incremental pressure from tariffs and slower coffee start.
Challenge rate by company
Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.
| Company | Questions | Challenge rate |
|---|---|---|
| PEP PepsiCo | 10 | 10%1 of 10 questions |
| PG The Procter & Gamble Company | 9 | 0%none of 9 questions |
| STZ Constellation Brands | 9 | 33%3 of 9 questions |
| CL Colgate-Palmolive | 8 | 13%1 of 8 questions |
| EL Estée Lauder Companies (The) | 7 | 0%none of 7 questions |
| KO The Coca-Cola Company | 7 | 14%1 of 7 questions |
| MNST Monster Beverage | 7 | 0%none of 7 questions |
| KMB Kimberly-Clark | 6 | 17%1 of 6 questions |
| CHD Church & Dwight | 5 | 20%1 of 5 questions |
| CLX Clorox | 5 | 0%none of 5 questions |
- PEPPepsiCo · 10 questions10%1 of 10 questions
- PGThe Procter & Gamble Company · 9 questions0%none of 9 questions
- STZConstellation Brands · 9 questions33%3 of 9 questions
- CLColgate-Palmolive · 8 questions13%1 of 8 questions
- ELEstée Lauder Companies (The) · 7 questions0%none of 7 questions
- KOThe Coca-Cola Company · 7 questions14%1 of 7 questions
- MNSTMonster Beverage · 7 questions0%none of 7 questions
- KMBKimberly-Clark · 6 questions17%1 of 6 questions
- CHDChurch & Dwight · 5 questions20%1 of 5 questions
- CLXClorox · 5 questions0%none of 5 questions
Activity by reporting period
Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.
| Calendar period | Questions | Challenge rate | Companies |
|---|---|---|---|
| 2024 Q3 | 5 | 0%none of 5 questions | 4 |
| 2024 Q4 | 12 | 0%none of 12 questions | 10 |
| 2025 Q1 | 14 | 29%4 of 14 questions | 11 |
| 2025 Q2 | 10 | 10%1 of 10 questions | 9 |
| 2025 Q3 | 7 | 0%none of 7 questions | 7 |
| 2025 Q4 | 7 | 14%1 of 7 questions | 7 |
| 2026 Q1 | 13 | 8%1 of 13 questions | 9 |
| 2026 Q2 | 6 | 17%1 of 6 questions | 6 |
| 2026 Q3 | 3 | 0%none of 3 questions | 2 |
- 2024 Q35 questions · challenge rate 0% (none of 5 questions) · 4 companies
- 2024 Q412 questions · challenge rate 0% (none of 12 questions) · 10 companies
- 2025 Q114 questions · challenge rate 29% (4 of 14 questions) · 11 companies
- 2025 Q210 questions · challenge rate 10% (1 of 10 questions) · 9 companies
- 2025 Q37 questions · challenge rate 0% (none of 7 questions) · 7 companies
- 2025 Q47 questions · challenge rate 14% (1 of 7 questions) · 7 companies
- 2026 Q113 questions · challenge rate 8% (1 of 13 questions) · 9 companies
- 2026 Q26 questions · challenge rate 17% (1 of 6 questions) · 6 companies
- 2026 Q33 questions · challenge rate 0% (none of 3 questions) · 2 companies
Topics
Topics tagged on this analyst’s questions.
- Demand30
- Competitive Dynamics28
- Revenue Growth13
- Cost Pressure13
- Pricing13
- Geographic Expansion12
- Guidance Reliability10
- Macroeconomic9
- Margin8
- Product Launch6
Show all 17 topics
- Capital Allocation6
- Fx5
- Supply Chain4
- Capex Investment4
- M&A3
- Innovation & R&D3
- Trade Tariffs3